Across the United States distribution of the Johnson & Johnson single-dose vaccine has been suspended following a Federal Alert from the CDC and FDA according to reports from various media sources. This suspension comes after what they are calling a “rare blood clotting” complication called cerebral venous sinus thrombosis (CVST). More than 6.8 million doses of the J&J vaccine have already been administered in the U.S.
According to The New York Times,
“Injections of Johnson & Johnson’s single-dose coronavirus vaccine came to a sudden halt in much of the United States on Tuesday after federal health agencies called for a pause in the vaccine’s use following the emergence of a rare blood clotting in six recipients within one to three weeks of vaccination. The virus is also surging in some parts of the U.S.”
“CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution.
This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.”
US Pharmacy Chains Respond To Federal Alert
All of the major US Pharmacy chains have responded to the Federal Alert by suspending distribution of the J&J vaccine including CVS, Walgreens and Rite Aid (Owned by Walgreens).
According to ABC affiliate WCVB,
CVS Pharmacy and Walgreens said they are pausing the use of Johnson & Johnson’s vaccine per the recommendation of federal health agencies.
“Following today’s recommendation from the FDA and CDC for a pause in the use of the J&J vaccine out of an abundance of caution, we are immediately suspending the administration of the J&J vaccine at our stores and off-site clinics and are awaiting further guidance,” Walgreens corporate spokesperson Erin Loverher said in a statement. “We are reaching out to patients with scheduled appointments and rescheduling vaccinations from other manufacturers, as supply allows.”
This announcement comes after 15 million doses of the J&J coronavirus vaccine had to be discarded last month as it failed quality standards, while the problem was spotted before any of the bad doses shipped. But the damage seems to be done. Between the new Federal Alert due to the blood clotting side affects, quality control issues and an already skeptical public, the Biden-Harris regime’s efforts to vaccinate the American people are likely to be severely impaired.